Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Cboe UK • GBp Indivior PLC (INDVL.XC) Follow Add holdings 861.25 -7.50 (-0.86%) At close: 4:29:51 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for INDVL.XC 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: INDVL.XC View More All News Press Releases SEC Filings Indivior First Quarter 2025 Earnings: Beats Expectations Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates Indivior Announces Q1 2025 Financial Results Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks’ Oaktree Capital Management? Indivior Insiders Placed Bullish Bets Worth US$1.42m Indivior Announces Further Changes to Board of Directors Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now? Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags